Active Biotech AB

251 articles about Active Biotech AB

• Annual General Meeting of Active Biotech AB

  5/17/2013

• New Data to be Presented at the 2013 American Society of Clinical Oncology Annual Meeting Show Active Biotech AB's Commitment to Oncology Research

  5/16/2013

• New Data to be Presented at the 2013 American Society of Clinical Oncology Annual Meeting Show Active Biotech AB's Commitment to Oncology Research

  5/16/2013

• Annual General Meeting of Active Biotech AB

  5/16/2013

• Active Biotech AB Interim Report January - March 2013

  4/25/2013

• Active Biotech AB and Ipsen Update the Analysis Plan for the 10TASQ10 Trial Evaluating Tasquinimod in the Treatment of Prostate Cancer

  4/25/2013

• Annual Report 2012 Active Biotech AB (publ)

  4/15/2013

• Active Biotech AB - Notice of Annual General Meeting of Shareholders

  4/11/2013

• Active Biotech AB - Notice of Annual General Meeting of Shareholders

  4/11/2013

• Number of Shares and Votes in Active Biotech AB

  3/28/2013

• Teva Pharmaceutical Industries Limited and Active Biotech AB See Positive Results From MS Study

  3/21/2013

• Active Biotech AB Raises $43 Million

  3/6/2013

• Active Biotech AB Year-End Report January - December 2012

  2/14/2013

• Results From Active Biotech AB's Phase II/III ANYARA Trial for the Treatment of Renal Cell Cancer

  1/28/2013

• Active Biotech AB to Present at the JP Morgan 31st Annual Healthcare Conference

  1/3/2013

• Active Biotech AB to Present at the J.P. Morgan 31st Annual Healthcare Conference

  1/3/2013

• Active Biotech AB Release: Laquinimod Highlights From Teva Pharmaceutical Industries Limited Investor Day December 11

  12/12/2012

• Active Biotech AB to Get $12.9 Million Milestone Payment

  12/10/2012

• Active Biotech AB and Ipsen Announce Completion of Recruitment of Tasquinimod Clinical Phase III Study in Prostate Cancer

  12/10/2012

• Active Biotech AB's Election Committee Appointed

  11/15/2012